|
| | Publication Year | Title | Author(s) |
| 1 | Mar-2022 | The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours. | Foo, Tiffany; Goldstein, David; Segelov, Eva; Shapiro, Jeremy; Pavlakis, Nick; Desai, Jayesh; Yip, Desmond; Zalcberg, John; Price, Timothy J; Nagrial, Adnan; Chantrill, Lorraine; Burge, Matt; Karapetis, Christos S; Tebbutt, Niall C ; Roy, Amitesh C |
| 2 | 24-Jan-2022 | VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer. | Chionh, Fiona; Gebski, Val; Al-Obaidi, Sheren J; Mooi, Jennifer K ; Bruhn, Maressa A; Lee, Chee K; Chüeh, Anderly C; Williams, David S ; Weickhardt, Andrew J ; Wilson, Kate; Scott, Andrew M ; Simes, John; Hardingham, Jennifer E; Price, Timothy J; Mariadason, John M ; Tebbutt, Niall C |
| 3 | Jan-2022 | Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. | Nguyen, Mike ; Segelov, Eva; Goldstein, David; Pavlakis, Nick; Shapiro, Jeremy; Price, Timothy J; Nagrial, Adnan; Chantrill, Lorraine; Leong, Trevor; Chen, John; Burge, Matt; Karapetis, Christos S; Chau, Ian; Lordick, Florian; Renouf, Daniel; Tebbutt, Niall C ; Roy, Amitesh C |
| 4 | 5-Nov-2021 | Update on optimal management for pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. | Nguyen, Mike ; Segelov, Eva; Goldstein, David; Pavlakis, Nick; Shapiro, Jeremy; Price, Timothy J; Nagrial, Adnan; Chantrill, Lorraine; Leong, Trevor; Chen, John; Burge, Matt; Karapetis, Christos S; Chau, Ian; Lordick, Florian; Renouf, Daniel; Tebbutt, Niall C ; Roy, Amitesh C |
| 5 | 15-Apr-2021 | Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study. | Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy J; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C |
| 6 | 15-Feb-2021 | Prognostic Significance of Post-Surgery Circulating Tumor DNA in Non-Metastatic Colorectal Cancer: Individual Patient Pooled Analysis of Three Cohort Studies. | Tie, Jeanne; Cohen, Joshua D; Lo, Serigne N; Wang, Yuxuan; Li, Lu; Christie, Michael; Lee, Margaret; Wong, Rachel; Kosmider, Suzanne; Skinner, Iain; Wong, Hui Li; Lee, Belinda; Burge, Matthew E; Yip, Desmond; Karapetis, Christos S; Price, Timothy J; Tebbutt, Niall C ; Haydon, Andrew M; Ptak, Janine; Schaeffer, Mary J; Silliman, Natalie; Dobbyn, Lisa; Popoli, Maria; Tomasetti, Cristian; Papadopoulos, Nickolas; Kinzler, Kenneth W; Vogelstein, Bert; Gibbs, Peter |
| 7 | Apr-2020 | Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO Congress 2019. | Lau, David K ; Burge, Matthew; Roy, Amitesh; Chau, Ian; Haller, Daniel G; Shapiro, Jeremy D; Peeters, Marc; Pavlakis, Nick; Karapetis, Christos S; Tebbutt, Niall C ; Segelov, Eva; Price, Timothy J |
| 8 | Mar-2019 | Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20. | Wells, J Connor; Tu, Dongsheng; Siu, Lillian L; Shapiro, Jeremy D; Jonker, Derek J; Karapetis, Christos; Simes, John; Liu, Geoffrey; Price, Timothy J; Tebbutt, Niall C ; O'Callaghan, Chris J |
| 9 | Dec-2018 | Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. | Shapiro, Jeremy D; Thavaneswaran, Subotheni; Underhill, Craig R; Robledo, Kristy P; Karapetis, Christos S; Day, Fiona L; Nott, Louise M; Jefford, Michael; Chantrill, Lorraine A; Pavlakis, Nick; Tebbutt, Niall C ; Price, Timothy J; Khasraw, Mustafa; Van Hazel, Guy A; Waring, Paul M; Tejpar, Sabine; Simes, John; Gebski, Val J; Desai, Jayesh; Segelov, Eva |
| 10 | 28-Nov-2018 | Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20. | Wells, J Connor; Tu, Dongsheng; Siu, Lillian L; Shapiro, Jeremy D; Jonker, Derek J; Karapetis, Christopher S; Simes, John; Liu, Geoffrey; Price, Timothy J; Tebbutt, Niall C ; O'Callaghan, Chris J |
| 11 | Oct-2018 | Targeted therapy for metastatic colorectal cancer. | Price, Timothy J; Tang, Monica; Gibbs, Peter; Haller, Daniel G; Peeters, Marc; Arnold, Dirk; Segelov, Eva; Roy, Amitesh; Tebbutt, Niall C ; Pavlakis, Nick; Karapetis, Chris; Burge, Matthew; Shapiro, Jeremy |
| 12 | Apr-2018 | Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study. | Lau, David K ; Tay, Rebecca Y; Yeung, Yvonne H ; Chionh, Fiona; Mooi, Jennifer; Murone, Carmel ; Skrinos, Effie; Price, Timothy J; Mariadason, John M ; Tebbutt, Niall C |
| 13 | Oct-2016 | MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial | Gormly, Kirsten L; Coscia, Claudio; Wells, Tim; Tebbutt, Niall C ; Harvey, Jennifer A; Wilson, Kate; Schmoll, Hans-Joachim; Price, Timothy J |
| 14 | 15-May-2016 | Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer. | Liu, Geoffrey; Tu, Dongsheng; Lewis, Marcia; Cheng, Dangxiao; Sullivan, Leslie A; Chen, Zhuo; Morgen, Eric; Simes, John; Price, Timothy J; Tebbutt, Niall C ; Shapiro, Jeremy D; Jeffery, G Mark; Mellor, J Daniel; Mikeska, Thomas; Virk, Shakeel; Shepherd, Lois E; Jonker, Derek J; O'Callaghan, Christopher J ; Zalcberg, John R; Karapetis, Christos S; Dobrovic, Alexander |
| 15 | May-2016 | Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015. | Price, Timothy J; Thavaneswaran, Subotheni; Burge, Matthew; Segelov, Eva; Haller, Daniel G; Punt, Cornelis Ja; Arnold, Dirk; Karapetis, Christos S; Tebbutt, Niall C ; Pavlakis, Nick; Gibbs, Peter; Shapiro, Jeremy D |
| 16 | Mar-2016 | Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial | Tebbutt, Niall C ; Price, Timothy J; Ferraro, Danielle A; Wong, Nicole; Veillard, Anne-Sophie; Hall, Merryn; Sjoquist, Katrin M; Pavlakis, Nick; Strickland, Andrew; Varma, Suresh C; Cooray, Prasad; Young, Rosemary; Underhill, Craig; Shannon, Jennifer A; Ganju, Vinod; Gebski, Val J |
| 17 | 14-Aug-2015 | Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature. | Chan, David L; Pavlakis, Nick; Shapiro, Jeremy; Price, Timothy J; Karapetis, Christos S; Tebbutt, Niall C ; Segelov, Eva |
| 18 | 17-Mar-2015 | Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer. | Price, Timothy J; Bruhn, M A; Lee, C K; Hardingham, J E; Townsend, A R; Mann, K P; Simes, J; Weickhardt, A ; Wrin, J W; Wilson, K; Gebski, V; Van Hazel, G; Robinson, B; Cunningham, D; Tebbutt, Niall C |
| 19 | 29-Jul-2014 | The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials. | Segelov, E; Chan, David L; Shapiro, J; Price, Timothy J; Karapetis, C S; Tebbutt, Niall C ; Pavlakis, N |
| 20 | 12-Dec-2013 | Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer. | Jonker, D J; Karapetis, C S; Harbison, C; O'Callaghan, Christopher J ; Tu, D; Simes, R J; Malone, D P; Langer, C; Tebbutt, Niall C ; Price, Timothy J; Shapiro, J; Siu, L L; Wong, R P W; Bjarnason, G; Moore, M J; Zalcberg, John R; Khambata-Ford, S |
Loading...
2
0
20
0
false